Bayer's Canesten Switched From Rx-To-OTC Status In Poland
Executive Summary
Poland's drug regulator, URPL, has switched Bayer's Canesten vaginal yeast infection treatment from prescription-to-OTC status. It is the regulator's fourth switch in 2019 alone.